Leaps by Bayer co-led a $55m series A round for cancer immunotherapy developer Triumvira Immunologics and is getting two board seats.

American Express Ventures and Citi Ventures have exited flight insurance software developer Freebird in an acquisition by Capital One.

The disaster prediction platform developer has signed a multi-year agreement with insurance firm Sompo Holdings, which had already backed its series B round.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The American Express-backed eyeglasses e-commerce platform has increased its valuation from $1.75bn to $3bn following series F and G rounds.

O'Reilly's OATV vehicle will exit web cybersecurity software provider in a deal consisting of $200m in cash and $575m of Fastly stock.

Intel Capital came in as a new investor for a round that pushed the genome engineering technology provider's overall funding to $260m.

The TTO reported decreased spinout generation, licensing revenue and funding however marked a notable exit in the sale of Tissue Analytics.

The healthcare data producer raised $19m from investors including Johnson & Johnson for a round already including Amgen, McKesson, Horizon Health Services, Sanofi and UCB Pharma.